» Articles » PMID: 23698058

The Ameliorative Effect of Sophoricoside on Mast Cell-mediated Allergic Inflammation in Vivo and in Vitro

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2013 May 24
PMID 23698058
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Sophoricoside exhibits numerous pharmacological effects, including anti- inflammatory and anti-cancer actions, yet the exact mechanism that accounts for the anti-allergic effects of sophoricoside is not completely understood. The aim of the present study was to elucidate whether and how sophoricoside modulates the mast cell-mediated allergic inflammation in vitro and in vivo. We investigated the pharmacological effects of sophoricoside on both compound 48/80 or histamine-induced scratching behaviors and 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis in mice. Additionally, to find a possible explanation for the anti-inflammatory effects of sophoricoside, we evaluated the effects of sophoricoside on the production of histamine and inflammatory cytokines and activation of nuclear factor-κB (NF-κB) and caspase-1 in phorbol 12-myristate 13-acetate plus calcium ionophore A23187 (PMACI)-stimulated human mast cells (HMC-1). The finding of this study demonstrated that sophoricoside reduced compound 48/80 or histamine-induced scratching behaviors and DNCB-induced atopic dermatitis in mice. Additionally, sophoricoside inhibited the production of inflammatory cytokines as well as the activation of NF-κB and caspase-1 in stimulated HMC-1. Collectively, the findings of this study provide us with novel insights into the pharmacological actions of sophoricoside as a potential molecule for use in the treatment of allergic inflammation diseases.

Citing Articles

Sophoricoside reduces inflammation in type II collagen-induced arthritis by downregulating NLRP3 signaling.

Liu Y, Zhao Y, Guo Q, Wang P, Li P, Du Q Biochem Biophys Rep. 2024; 40:101867.

PMID: 39610833 PMC: 11603010. DOI: 10.1016/j.bbrep.2024.101867.


Characterization of a novel galectin in and its role in regulating macrophage functions.

He R, Zhang Q, Xu L, Guo M, Gu X, Xie Y Front Microbiol. 2023; 14:1251475.

PMID: 37692380 PMC: 10484005. DOI: 10.3389/fmicb.2023.1251475.


Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy.

Gao M, Hu F, Hu M, Hu Y, Shi H, Zhao G Biosci Rep. 2020; 40(11).

PMID: 32964914 PMC: 7677750. DOI: 10.1042/BSR20200661.


Chinese medicines reported to have effects on contact dermatitis in the last 20 years.

Jung Y, Kim B, Ryu M, Kim H Chin J Integr Med. 2017; 24(1):64-71.

PMID: 28251475 DOI: 10.1007/s11655-016-2535-9.


Modulation of lipogenesis and glucose consumption in HepG2 cells and C2C12 myotubes by sophoricoside.

Wu C, Luan H, Wang S, Zhang X, Wang R, Jin L Molecules. 2013; 18(12):15624-35.

PMID: 24352018 PMC: 6270613. DOI: 10.3390/molecules181215624.

References
1.
Galli S, Kalesnikoff J, Grimbaldeston M, Piliponsky A, Williams C, Tsai M . Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005; 23:749-86. DOI: 10.1146/annurev.immunol.21.120601.141025. View

2.
Shiohara T, Hayakawa J, Mizukawa Y . Animal models for atopic dermatitis: are they relevant to human disease?. J Dermatol Sci. 2004; 36(1):1-9. DOI: 10.1016/j.jdermsci.2004.02.013. View

3.
Leung D, Bieber T . Atopic dermatitis. Lancet. 2003; 361(9352):151-60. DOI: 10.1016/S0140-6736(03)12193-9. View

4.
Kim B, Chung E, Min B, Lee S, Kim M, Min K . Anti-inflammatory action of legume isoflavonoid sophoricoside through inhibition on cyclooxygenase-2 activity. Planta Med. 2003; 69(5):474-6. DOI: 10.1055/s-2003-39712. View

5.
Sugimoto Y, Umakoshi K, Nojiri N, Kamei C . Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice. Eur J Pharmacol. 1998; 351(1):1-5. DOI: 10.1016/s0014-2999(98)00288-x. View